Osteo-Pharma and Emultech Announce Joint Venture to Develop First-in-Class Disease-Modifying Treatment for Osteoarthritis
17 nov. 2021 06h00 HE
|
Bone-Tech
AMSTERDAM, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Emultech and Osteo-Pharma today announced a joint venture, Bone-Tech, to develop what could be the first disease-modifying treatment for osteoarthritis...